|
Oct 3
|
SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development…
|
|
Oct 3
|
Soligenix Announces Partnership with Sterling Pharma Solutions
|
|
Aug 1
|
Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian Poligone
|
|
Jun 25
|
Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma
|
|
Jun 14
|
A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
|
|
Jun 14
|
SNGX: Valuation Change Based on Reverse Split…
|
|
May 29
|
Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
|
|
May 21
|
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
|
|
May 21
|
SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
|
|
May 20
|
Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
|
|
May 16
|
Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
|
|
Feb 8
|
Soligenix Announces Formation of Behçet's Disease Medical Advisory Board
|
|
Jan 10
|
SNGX: Phase 2a Psoriasis Trial Achieves Clinical Success…
|
|
Jan 2
|
Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
|
|
Dec 9
|
Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fair
|
|
Dec 1
|
"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery
|
|
Nov 30
|
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease
|
|
Nov 20
|
SNGX: Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperature…
|
|
Nov 17
|
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
|
|
Aug 11
|
BioVie and Soligenix Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
|